Salidroside exerts anti-tumor effects in ovarian cancer by inhibiting STAT3/c-Myc pathway-mediated glycolysis. (2024). Biomolecules and Biomedicine, 25(1), 82–93. https://doi.org/10.17305/bb.2024.10867